Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Meghan E. McIlwain"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2011, Iss default, Pp 135-149 (2011)
Meghan E Mcilwain1,2, Jeff Harrison1, Amanda J Wheeler1,3, Bruce R Russell1,21School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 2Centre for Brain Research, Faculty of Medical and Health Science
Externí odkaz:
https://doaj.org/article/36b5e466ed7f4db5b9ccd890eec48990
Autor:
John Lauriello, Akira Sawa, Elias Mouchlianitis, Lawrence S. Kegeles, Edith J. Liemburg, Lijing Xin, Oswald J.N. Bloemen, Jürgen R. Reichenbach, Fei Du, Charles Gasparovic, Cedric E. Ginestet, Eric Plitman, Oliver D. Howes, Sotirios Posporelis, Stephen J. Wood, Peter Jeon, Jeffrey A. Stanley, Arsime Demjaha, Jürgen Gallinat, Agata Szulc, Alice Egerton, Peter C. Williamson, Aristides A. Capizzano, Dost Öngür, Jennifer M. Coughlin, Christos Pantelis, Matcheri S. Keshavan, Scot E. Purdon, H-Mrs in Schizophrenia Investigators, Ariel Graff-Guerrero, Jean Théberge, Lena Palaniyappan, Reggie Taylor, Therese van Amelsvoort, Faith Borgan, Igor Nenadic, Sameer Jauhar, Sang-Young Kim, Camilo de la Fuente-Sandoval, Beata Galińska-Skok, Philip McGuire, Meghan E. McIlwain, Charles A. Kaufmann, Jun Nakamura, Beng Choon Ho, André Aleman, Philip G. Tibbo, James M. Stone, Jerzy Walecki, Kate Merritt, Tadafumi Kato, Hiroshi Kunugi, Kim Q. Do, Bruce R. Russell, Wolfgang Block, Kara Dempster, Martin Schaefer, Peter Falkai, Dikoma C. Shungu, Miho Ota, Gemma Modinos, Naoki Goto, Hidenori Yamasue, Juan R. Bustillo, Perry F. Renshaw, Stefan Smesny, Katy Thakkar
Publikováno v:
JAMA Psychiatry
JAMA Psychiatry, 78(6), 667-681. American Medical Association
Brain and Mind Institute Researchers' Publications
Jama psychiatry, 78(6), 667-681. AMER MEDICAL ASSOC
JAMA Psychiatry, 78(6), 667-681. American Medical Association
Brain and Mind Institute Researchers' Publications
Jama psychiatry, 78(6), 667-681. AMER MEDICAL ASSOC
Key Points Question Are clinical and demographic factors associated with brain glutamate or glutamate plus glutamine (Glx) levels in schizophrenia? Findings In this mega-analysis of 1251 patients with schizophrenia and 1197 healthy volunteers, medial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85e68f0602bd6e1961dcf0a6911b7886
https://pubmed.ncbi.nlm.nih.gov/33881460
https://pubmed.ncbi.nlm.nih.gov/33881460
Autor:
Carolyn Beth McNabb, Frederick Sundram, Valerie M. Anderson, Robert R. Kydd, Meghan E. McIlwain, Bruce R. Russell
Treatment response in schizophrenia is heterogeneous and has been posited to divide into three distinct subcategories: treatment-responsive (first-line responders; FLR), treatment-resistant (TRS, responding to clozapine), and ultra-treatment-resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706737543ef34fe8862e5d8cc6a066f9
https://doi.org/10.1101/19010777
https://doi.org/10.1101/19010777
Autor:
Valerie M. Anderson, Robert R. Kydd, Carolyn Beth McNabb, Bruce R. Russell, Meghan E. McIlwain, Frederick Sundram
Publikováno v:
Psychiatry Research: Neuroimaging. 305:111198
Treatment response in schizophrenia divides into three subcategories: treatment-responsive (first-line responders; FLR), treatment-resistant (TRS), and ultra-treatment-resistant schizophrenia (UTRS). White matter abnormalities could drive antipsychot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4750f632634fd981f74206bd93dee688
https://doi.org/10.1016/j.pscychresns.2020.111198
https://doi.org/10.1016/j.pscychresns.2020.111198
Autor:
Valerie M. Anderson, Roger Tait, John Suckling, Robert R. Kydd, Bruce R. Russell, Carolyn Beth McNabb, Meghan E. McIlwain
Publikováno v:
Schizophrenia research. 195
Schizophrenia may develop from disruptions in functional connectivity regulated by neurotransmitters such as dopamine and acetylcholine. The modulatory effects of these neurotransmitters might explain how antipsychotics attenuate symptoms of schizoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011ce9d9c6e9eac291cd895c8680169b
https://pubmed.ncbi.nlm.nih.gov/29042073
https://pubmed.ncbi.nlm.nih.gov/29042073
Publikováno v:
Neuropsychiatric Disease and Treatment
Neuropsychiatric Disease and Treatment, Vol 2011, Iss default, Pp 135-149 (2011)
Neuropsychiatric Disease and Treatment, Vol 2011, Iss default, Pp 135-149 (2011)
Meghan E Mcilwain1,2, Jeff Harrison1, Amanda J Wheeler1,3, Bruce R Russell1,21School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 2Centre for Brain Research, Faculty of Medical and Health Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade9932955a559d96d4bd0092a70f92e
http://europepmc.org/articles/PMC3083987
http://europepmc.org/articles/PMC3083987
Publikováno v:
Psychiatry research. 230(3)
This study aimed to investigate whether cognitive impairment is more pronounced in people with treatment-resistant schizophrenia compared with those who respond well to first-line antipsychotic medication. Fifty-one patients with schizophrenia were a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c47a343b56c6f539ddae99a2ff821c82
https://pubmed.ncbi.nlm.nih.gov/26564550
https://pubmed.ncbi.nlm.nih.gov/26564550
Autor:
Bruce R. Russell, Robert R. Kydd, Carolyn Beth McNabb, Reggio N. Hartono, Nikola Kasabov, Valerie M. Anderson, Meghan E. McIlwain
Publikováno v:
Schizophrenia Research. 153:S361
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bea47968b5d3a74b4c85adf24697c2a
https://doi.org/10.1016/s0920-9964(14)71019-9
https://doi.org/10.1016/s0920-9964(14)71019-9